磷脂酶A2
败血症
调解人
肺表面活性物质
医学
肺
炎症
磷脂酶
内生
毒性
免疫学
药理学
杀伤力
呼吸系统
呼吸道疾病
弥漫性肺泡损伤
病理生理学
肺毒性
磷脂酶A
炎症反应
发病机制
呼吸衰竭
急性呼吸窘迫综合征
肺泡
作者
Jianyu Wang,Zhongxing Xu,Lin Wang,Xin Sui,Yuan Luo,Xiuli Zhao,Jun Yang,Yongan Wang
标识
DOI:10.1002/advs.202514915
摘要
This study reveals that phospholipase A2 (PLA2), normally stable and nontoxic, can be activated specifically within the alveolar environment to induce rapid, "electric shock-like" lethality, akin to chemical toxins, while also exhibiting extreme toxicity comparable to that of biological toxins, and functioning as a potential "time bomb" in the body. When exacerbated inflammation impairs the pulmonary barrier, PLA2 from the circulation can penetrate into the lungs. Once activated in the alveolar space, it rapidly hydrolyzes pulmonary surfactant phospholipids, causing a drastic decline in surface tension (>30%). This leads to alveolar overdistension, instantaneous respiratory failure, and asphyxiation-an acute mortality effect strikingly similar to that observed in sepsis and severe pulmonary diseases. PLA2 penetration and lethality are more pronounced in aged animals. Based on these findings, a combination therapy comprising phospholipase (dioleoylphosphatidylserine) and an inhibitor (varespladib) was developed, which significantly improved survival rates from 0% to over 90% in mice with sepsis, acute lung injury, and PLA2 poisoning. This study provides critical theoretical foundations and intervention strategies for the clinical treatment of related diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI